Application of boosted trees to the prognosis prediction of COVID-19.
Sajjad MolaeiHadi MoazenHamid Reza NiazkarMasoud SabaeiMasoumeh Ghoddusi JohariAbbas RezaianzadehPublished in: Health science reports (2024)
The current study indicated that both EBM and XGBoost could predict the ICU admission and mortality of COVID-19 cases based on routine hematological and clinical chemistry evaluation at the time of admission. Also, based on the results, AST, lymphocyte count, and BUN levels could be used as early predictors of COVID-19 prognosis.